which need long-term management and it is only recently that we have really been looking at the effects of long-term management, both the advantages and the disadvantages. One has to assess both, of course, in making any rational decision. We are in this area now with the affective disorders. We know that people who have had three or four affective disorders will go on having them probably for the rest of their lives and I would suspect that investigations on the course and history of schizophrenia have revealed much the same thing.
One is really moving into the evaluation of management schemes and I think there is a great need for this. How long should we continue medication? The answer is that we do not know. Take the patient off, gently perhaps, and see what happens. Give him a chance to emerge from the change in chemistry before you rashly put him back. We do not really have anything but our rather crude clinical assessment of the situation. But I do agree, and one or two speakers have made the same point, that we really must give the patients the chance of not being on medication.
